Title: Europe Cell Line Development Market may exceed USD 2.1 billion by 2024
1 Europe Cell Line Development Market to reach USD
2.1bn by 2024 Graphical Research
2018 Graphical Research. All rights
reserved.
www.graphicalresearch.com
2 Key Insights from Europe Cell Line Development
Market
- Graphical Research says, Europe Cell Line
Development Market to reach USD 2.1bn by 2024 - Growing disease burden across the globe is the
key factor that will drive cell line development
market growth. - Rising demand for vaccines and monoclonal
antibodies in treatment of cancer, autoimmune
diseases and anti-inflammatory disease will fuel
demand for cell line cultures. - Developments in biotechnology industry,
increasing healthcare expenditure coupled with
growing adoption of technologically advanced
products should accelerate the cell line
development industry growth. - Technological advancements in cell line
development products is another major contributor
for cell line development business growth.
Availability of automated screening methods,
enriched medias, disposable equipment and
improved expression systems for enhancing cell
line development practices will foster market
growth.
2018 Graphical Research. All rights
reserved.
www.graphicalresearch.com
3 Continued...
- Reagents and media product segment accounted for
largest market share of 53.6 in 2017 and is
projected to show robust growth throughout the
analysis period. - Mammalian cell cultures segment was valued at USD
650.8 million in 2017 and is estimated to show
similar growth during the forecast period. - Recombinant cell line type segment is anticipated
to grow at 12.5 CAGR during the forthcoming
years. Advent of rDNA technology has drastically
increased the demand for recombinant cell lines - Germany cell line development market will grow
considerably during the forecast period owing to
increasing disease burden in the region. Growing
adoption of vaccines and monoclonal antibodies
will foster cell line development industry
growth. - Key industry players operating in Europe cell
line development market are Selexis, Sartorius,
Lonza Group, Samsung Biologics, WuXi AppTec, GE
Healthcare, Thermo Fisher Scientific, The
European Collection of Cell Cultures,
Sigma-Aldrich (Merck), GVK BIO, and Progenitor
Cell Therapy.
2018 Graphical Research. All rights
reserved.
www.graphicalresearch.com
4 Browse Full Market Research Report On Europe Cell
Line Development Market _at_ https//bit.ly/2N4VHQC
Request for a Sample of this Research
Report _at_ https//bit.ly/2zs5k88
2018 Graphical Research. All rights
reserved.
www.graphicalresearch.com
5 Stay In Touch With Us For
Website www.graphicalresearch.com Socia
l Media
Assured Quality
On-Time Delivery
Industry Experts
Payment Security
2018 Graphical Research. All rights
reserved.
www.graphicalresearch.com